Richard Peluso

Merck & Co., Inc., Rahway, NJ, USA (United States) — United States

Medicine · Health Sciences

28h-index3.2kcitations50works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virology and Viral Diseases(21), Virus-based gene therapy research(18), Animal Virus Infections Studies(10), Viral Infectious Diseases and Gene Expression in Insects(10), Respiratory viral infections research(9)

Publications50 total

Use of flow cytometry for characterization of human cytomegalovirus vaccine particles
Vaccine·2016· 33 cited
Respiroviruses: Parainfluenza Virus
2010
Manufacturing Recombinant Adeno-Associated Viral Vectors from Producer Cell Clones
Human Gene Therapy·2009· 73 cited
Diabetes mellitus and coronary risk.
PubMed·2009
Adeno-Associated Virus and AAV Vectors for Gene Delivery
2008· 7 cited
Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi
Proceedings of the National Academy of Sciences·2008· 606 citedOpen Access
Reversal of Cardiac Dysfunction After Long-Term Expression of SERCA2a by Gene Transfer in a Pre-Clinical Model of Heart Failure
Journal of the American College of Cardiology·2008· 337 cited
Abstract 321: Cardiac Function Improvement Following In vivo Intracoronary Adeno-Associated Virus Type 1 Vector Gene Transfer of SERCA2a in a Pre-Clinical Model of Heart Failure
Circulation·2007· 1 cited
Characterizing clearance of helper adenovirus by a clinical rAAV1 manufacturing process
Biologicals·2007· 9 cited
The Manufacture of Adeno‐Associated Viral Vectors
2007· 1 cited
Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins
Journal of Molecular and Cellular Cardiology·2007· 128 citedOpen Access
312. Clearance of Helper Adenovirus by an AAV1 Clinical Vector Manufacturing Process
Molecular Therapy·2006Open Access
414. Non-Allele Specific RNA Interference in the CAG140 Knock-In Mouse Model of Huntington's Disease
Molecular Therapy·2006Open Access
499. Improving the Stability of Ad-AAV Hybrid Vectors
Molecular Therapy·2006
Secretion of a TNFR:Fc Fusion Protein following Pulmonary Administration of Pseudotyped Adeno-Associated Virus Vectors
Journal of Virology·2004· 34 citedOpen Access
Dual Therapeutic Utility of Proteasome Modulating Agents for Pharmaco-gene Therapy of the Cystic Fibrosis Airway
Molecular Therapy·2004· 49 citedOpen Access
Distinct Classes of Proteasome-Modulating Agents Cooperatively Augment Recombinant Adeno-Associated Virus Type 2 and Type 5-Mediated Transduction from the Apical Surfaces of Human Airway Epithelia
Journal of Virology·2004· 135 citedOpen Access
AAV2 Vector Harboring a Liver-Restricted Promoter Facilitates Sustained Expression of Therapeutic Levels of α-Galactosidase A and the Induction of Immune Tolerance in Fabry Mice
Molecular Therapy·2003· 135 cited
Adeno-associated Virus and AAV Vectors for Gene Delivery
2003· 2 cited
Production by Bacillus pumilus (MSH) of an antifungal compound that is active against Mucoraceae and Aspergillus species: preliminary report
Journal of Medical Microbiology·2002· 87 cited
page 1 of 3Next →

Frequent Co-authors

Anne Moscona(7), Haim Burstein(6), Sue A. Moyer(5), Barrie J. Carter(3), Ashley T. Haase(3), Linda Stowring(3), P. Ventura(3), Yoshiaki Kawase(3), Djamel Lebeche(3), Yoshiaki Takewa(3), Krisztina M. Zsebo(3), Roger J. Hajjar(3), Simon Godwin(3), Robert A. Lamb(3), Purnell W. Choppin(3), Ryan Takeya(3), Eric Pastor(3), Barrie Carter(3), James C. Richardson(3), Jodi L. McBride(2)